A Decision That Gets Harder to Reverse the Longer You Wait
As hemp brands scale production to capture the Q4 opportunity, many face a genuine capacity decision: contract with a co-packer to handle manufacturing, or invest in building in-house production capability. This decision has long-term implications that extend well past the current protected window.
The Case for Co-Packing
Speed to capacity. Co-packers already have equipment, trained staff, and regulatory infrastructure in place. For capturing the Q4 opportunity specifically, this speed advantage often outweighs other considerations.
Lower capital commitment. Building in-house production requires significant capital investment in equipment, facility buildout, and compliance infrastructure. Co-packing converts this to a variable cost tied to actual production volume.
Flexibility under regulatory uncertainty. Given the December 11 uncertainty discussed throughout this publication, a co-packing relationship offers more flexibility to scale up or down without being locked into fixed capital investments that assumed a specific regulatory outcome.
The Case for In-House Production
Quality control ownership. Direct control over every aspect of production, without depending on a third party's quality systems, though this requires building your own robust quality infrastructure.
Long-term cost efficiency. At sufficient volume, in-house production typically becomes more cost-efficient than paying co-packer margins, particularly for brands with a durable, multi-year growth trajectory.
Proprietary process protection. If your formulation or production process represents genuine competitive advantage, in-house production protects that IP more effectively than sharing it with a co-packer.
Questions to Guide the Decision
- What is your realistic production volume over the next 12-24 months, not just the current Q4 spike?
- How confident are you in your formulation's stability across different regulatory scenarios, given the compliance stakes discussed throughout this publication?
- Do you have the capital available for in-house investment without compromising other Q4 priorities like inventory and marketing?
- Is your competitive advantage tied to a proprietary process worth protecting, or to brand, distribution, and customer relationships that a co-packer relationship wouldn't compromise?
A Middle Path: Co-Packing Now, In-House Later
Many hemp brands find that co-packing during the current uncertain window, with a defined plan to evaluate in-house production once the permanent framework is clearer, offers the best balance of speed and long-term optionality. This avoids over-committing capital to a specific regulatory bet while still capturing the Q4 opportunity.
Evaluating Co-Packer Partners
If you choose the co-packing path, prioritize partners who can demonstrate GMP certification (discussed elsewhere in this publication), transparent compliance documentation practices, and enough production flexibility to scale with your Q4 growth without becoming a bottleneck.
Low Gravity Hemp works with both co-packing partners and in-house manufacturers, supplying compliant ingredients with documentation that supports either production model. Contact us to talk through your production strategy.
